Class information for: |
Basic class information |
| Class id | #P | Avg. number of references |
Database coverage of references |
|---|---|---|---|
| 20530 | 456 | 35.3 | 72% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
| Cluster id | Level | Cluster label | #P |
|---|---|---|---|
| 8 | 4 | CARDIAC & CARDIOVASCULAR SYSTEM//PERIPHERAL VASCULAR DISEASES//CARDIOL | 1276458 |
| 57 | 3 | ANGIOTENSIN II//HYPERTENSION//PERIPHERAL VASCULAR DISEASES | 89232 |
| 85 | 2 | ANGIOTENSIN II//RENIN ANGIOTENSIN SYSTEM//ANGIOTENSIN | 27105 |
| 20530 | 1 | CANDESARTAN//MALIGNANT STROKE PRONE SPONTANEOUSLY HYPERTENSIVE RAT//INTRAMURAL PROGRAMS | 456 |
Terms with highest relevance score |
| rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|---|
| 1 | CANDESARTAN | authKW | 149489 | 7% | 7% | 30 |
| 2 | MALIGNANT STROKE PRONE SPONTANEOUSLY HYPERTENSIVE RAT | authKW | 89282 | 0% | 67% | 2 |
| 3 | INTRAMURAL PROGRAMS | address | 86849 | 3% | 11% | 12 |
| 4 | ANGIOTENSIN II AT1 RECEPTOR BLOCKERS | authKW | 86091 | 1% | 43% | 3 |
| 5 | STROKE PRONE SPONTANEOUSLY HYPERTENSIVE RATS | authKW | 81280 | 4% | 7% | 17 |
| 6 | PROGRAM CLIN EXPT THER EUT | address | 75927 | 3% | 9% | 13 |
| 7 | 2 3 NAPHTHALENEDICARBOXYALDEHYDE | authKW | 66963 | 0% | 100% | 1 |
| 8 | 33 PERCENT FISH MEAL DIET | authKW | 66963 | 0% | 100% | 1 |
| 9 | A ADRENOCEPTOR AND B ADRENOCEPTOR BLOCKING DRUG | authKW | 66963 | 0% | 100% | 1 |
| 10 | AGING HEBREW SENIROLIFE | address | 66963 | 0% | 100% | 1 |
Web of Science journal categories |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | Peripheral Vascular Diseases | 7444 | 38% | 0% | 171 |
| 2 | Clinical Neurology | 580 | 17% | 0% | 76 |
| 3 | Pharmacology & Pharmacy | 507 | 21% | 0% | 97 |
| 4 | Neurosciences | 429 | 20% | 0% | 90 |
| 5 | Cardiac & Cardiovascular System | 236 | 10% | 0% | 46 |
| 6 | Physiology | 142 | 7% | 0% | 32 |
| 7 | Hematology | 71 | 5% | 0% | 21 |
| 8 | Medicine, Research & Experimental | 61 | 5% | 0% | 25 |
| 9 | Endocrinology & Metabolism | 44 | 5% | 0% | 23 |
| 10 | Medicine, General & Internal | 34 | 6% | 0% | 26 |
Address terms |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | INTRAMURAL PROGRAMS | 86849 | 3% | 11% | 12 |
| 2 | PROGRAM CLIN EXPT THER EUT | 75927 | 3% | 9% | 13 |
| 3 | AGING HEBREW SENIROLIFE | 66963 | 0% | 100% | 1 |
| 4 | DHHN | 66963 | 0% | 100% | 1 |
| 5 | EXPLORAT FONCT METAB | 66963 | 0% | 100% | 1 |
| 6 | HLTH HUMAN SERVSECT PHARMACOL | 66963 | 0% | 100% | 1 |
| 7 | HLTH HUMAN SERVSECT PHARMACOLDHHS | 66963 | 0% | 100% | 1 |
| 8 | HYPERTENS NEPHROL F03226 | 66963 | 0% | 100% | 1 |
| 9 | IDIPAZ HLTH STROKE NEUROSCI CEREBR | 66963 | 0% | 100% | 1 |
| 10 | MED GEORGIA HM 1200 | 66963 | 0% | 100% | 1 |
Journals |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | JOURNAL OF HYPERTENSION | 12810 | 9% | 0% | 43 |
| 2 | STROKE | 7112 | 9% | 0% | 39 |
| 3 | HYPERTENSION RESEARCH | 4552 | 3% | 1% | 13 |
| 4 | JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM | 3611 | 4% | 0% | 17 |
| 5 | JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM | 2734 | 1% | 1% | 6 |
| 6 | TRANSLATIONAL STROKE RESEARCH | 1358 | 1% | 1% | 3 |
| 7 | DICP-THE ANNALS OF PHARMACOTHERAPY | 1190 | 1% | 1% | 3 |
| 8 | AMERICAN JOURNAL OF HYPERTENSION | 1120 | 2% | 0% | 10 |
| 9 | JOURNAL OF STROKE & CEREBROVASCULAR DISEASES | 1024 | 1% | 0% | 6 |
| 10 | CURRENT HYPERTENSION REPORTS | 1019 | 1% | 0% | 4 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
| Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
|---|---|---|---|---|
| 1 | BRDON, J , KAISER, S , HAGEMANN, F , ZHAO, Y , CULMAN, J , GOHLKE, P , (2007) COMPARISON BETWEEN EARLY AND DELAYED SYSTEMIC TREATMENT WITH CANDESARTAN OF RATS AFTER ISCHAEMIC STROKE.JOURNAL OF HYPERTENSION. VOL. 25. ISSUE 1. P. 187-196 | 25 | 58% | 25 |
| 2 | GUTIERREZ-FERNANDEZ, M , FUENTES, B , RODRIGUEZ-FRUTOS, B , RAMOS-CEJUDO, J , OTERO-ORTEGA, L , DIEZ-TEJEDOR, E , (2015) DIFFERENT PROTECTIVE AND REPARATIVE EFFECTS OF OLMESARTAN IN STROKE ACCORDING TO TIME OF ADMINISTRATION AND WITHDRAWAL.JOURNAL OF NEUROSCIENCE RESEARCH. VOL. 93. ISSUE 5. P. 806 -814 | 22 | 55% | 0 |
| 3 | SAAVEDRA, JM , NISHIMURA, Y , (1999) ANGIOTENSIN AND CEREBRAL BLOOD FLOW.CELLULAR AND MOLECULAR NEUROBIOLOGY. VOL. 19. ISSUE 5. P. 553 -573 | 38 | 43% | 29 |
| 4 | EDVINSSON, L , (2008) CEREBROVASCULAR ANGIOTENSIN AT(1) RECEPTOR REGULATION IN CEREBRAL ISCHEMIA.TRENDS IN CARDIOVASCULAR MEDICINE. VOL. 18. ISSUE 3. P. 98-103 | 21 | 58% | 6 |
| 5 | VILLAPOL, S , BALAREZO, MG , AFFRAM, K , SAAVEDRA, JM , SYMES, AJ , (2015) NEURORESTORATION AFTER TRAUMATIC BRAIN INJURY THROUGH ANGIOTENSIN II RECEPTOR BLOCKAGE.BRAIN. VOL. 138. ISSUE . P. - | 27 | 36% | 2 |
| 6 | FOUDA, AY , ARTHAM, S , EL-REMESSY, AB , FAGAN, SC , (2016) RENIN-ANGIOTENSIN SYSTEM AS A POTENTIAL THERAPEUTIC TARGET IN STROKE AND RETINOPATHY: EXPERIMENTAL AND CLINICAL EVIDENCE.CLINICAL SCIENCE. VOL. 130. ISSUE 4. P. 221 -238 | 39 | 21% | 2 |
| 7 | VILLAPOL, S , YASZEMSKI, AK , LOGAN, TT , SANCHEZ-LEMUS, E , SAAVEDRA, JM , SYMES, AJ , (2012) CANDESARTAN, AN ANGIOTENSIN II AT(1)-RECEPTOR BLOCKER AND PPAR-GAMMA AGONIST, REDUCES LESION VOLUME AND IMPROVES MOTOR AND MEMORY FUNCTION AFTER TRAUMATIC BRAIN INJURY IN MICE.NEUROPSYCHOPHARMACOLOGY. VOL. 37. ISSUE 13. P. 2817-2829 | 27 | 34% | 16 |
| 8 | NISHIMURA, Y , ITO, T , SAAVEDRA, JM , (2000) ANGIOTENSIN II AT(1) BLOCKADE NORMALIZES CEREBROVASCULAR AUTOREGULATION AND REDUCES CEREBRAL ISCHEMIA IN SPONTANEOUSLY HYPERTENSIVE RATS.STROKE. VOL. 31. ISSUE 10. P. 2478-2485 | 17 | 61% | 172 |
| 9 | KOZAK, W , KOZAK, A , JOHNSON, MH , ELEWA, HF , FAGAN, SC , (2008) VASCULAR PROTECTION WITH CANDESARTAN AFTER EXPERIMENTAL ACUTE STROKE IN HYPERTENSIVE RATS: A DOSE-RESPONSE STUDY.JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS. VOL. 326. ISSUE 3. P. 773 -782 | 15 | 63% | 26 |
| 10 | SAAVEDRA, JM , ITO, T , NISHIMURA, Y , (2001) THE ROLE OF ANGIOTENSIN II AT(1)-RECEPTORS IN THE REGULATION OF THE CEREBRAL BLOOD FLOW AND BRAIN ISCHAEMIA.JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM. VOL. 2. ISSUE . P. S102 -S109 | 24 | 48% | 2 |
Classes with closest relation at Level 1 |